13 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
2018 through February 2019. Mr. Johnson is the former lead independent director of Sucampo Pharmaceuticals, Inc., from 2016 until 2018, and a former … he served on the board of directors of Theravance Biopharma between 2013 and 2014 and as its lead independent director between 2014 and May 2023
6-K/A
EX-99.2
AUTL
Autolus Therapeutics plc
6 Jul 23
Current report (foreign) (amended)
5:38pm
and as interim Chief Executive Officer from October 2018 through February 2019. Mr. Johnson is the former lead independent director of Sucampo
6-K
EX-99.2
AUTL
Autolus Therapeutics plc
6 Jun 23
Current report (foreign)
8:18am
and as interim Chief Executive Officer from October 2018 through February 2019. Mr. Johnson is the former lead independent director of Sucampo
6-K
EX-1
AUTL
Autolus Therapeutics plc
1 Jul 22
Current report (foreign)
5:15pm
or membership and the role of Lead Independent Director or Chairperson. These fees are determined by the full Board of Directors, upon recommendation
6-K
3wat9e7k ycjt4e6
15 Sep 21
Autolus Therapeutics announces the appointment of John H. Johnson as non-executive chairman of its Board of Directors
4:30pm
6-K
EX-1
fvwtt rjq
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-1
52286 fx4z7ui
26 May 20
Current report (foreign)
4:31pm
6-K
EX-1
kupl7oxs
15 Mar 19
Annual Report and Accounts
5:26pm
20-F
EX-2.3
p3kkhv d2
23 Nov 18
Annual report (foreign)
12:00am
20-F
xgvig14
23 Nov 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next